Fresh2 Group Ltd (ANPC) Gross Profit Margin starting from the fourth quarter 2022 to fourth quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Fresh2 Group Ltd  (NASDAQ: ANPC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Fresh2 Group Ltd's Gross Profit Margin by quarter

Trends, Rankings, Statistics



ANPC Gross Profit Margin (Dec 31 2022)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2021)
Q4
Y / Y Revenue Change -38.13 %
Seq. Revenue Change -
Revenue In Millions $1.75
Gross Profit Margin 69.19 %
Gross Profit Margin Total Ranking # 1086
Gross Profit In Millions $1.21
Y / Y Gross Profit Change -37.18 %
Seq. Gross Profit Change -


Commenting fourth quarter 2022 Gross Profit Margin



Observing fourth quarter 2022 results within Medical Laboratories industry 10 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 1086.
Learn about Gross Margin
ANPC's Gross Profit Margin fourth quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry # 11
Healthcare Sector # 215
Overall # 1064

Gross Profit Margin Statistics
High Average Low
69.19 % 68.66 % 68.14 %
(Dec 31 2022)   (Dec 31 2021)




Other Gross Profit Margin Profitability Ratios
ANPC's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ANPC's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ANPC's Competitors
Gross Profit Margin Profit Margin for Fresh2 Group Ltd's Suppliers
Gross Profit Margin Profit Margin for ANPC's Customers

You may also want to know
ANPC's Annual Growth Rates ANPC's Profitability Ratios ANPC's Asset Turnover Ratio ANPC's Dividend Growth
ANPC's Roe ANPC's Valuation Ratios ANPC's Financial Strength Ratios ANPC's Gross Profit Growth
ANPC's Roa ANPC's Inventory Turnover Ratio ANPC's Growth Rates ANPC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2022, within Medical Laboratories Industry Gross Profit MarginDec 31 2022 MRQ Gross ProfitDec 31 2022 MRQ Revenue
Incyte Corporation  93.62 %$ 867.537  Millions$ 926.700  Millions
Bioaffinity Technologies Inc   91.21 %$ 0.003  Millions$ 0.004  Millions
Maxcyte inc   87.55 %$ 10.877  Millions$ 12.424  Millions
Vyant Bio Inc   86.96 %$ 0.040  Millions$ 0.046  Millions
Caredx Inc   77.35 %$ 63.727  Millions$ 82.384  Millions
Veracyte Inc   75.85 %$ 60.903  Millions$ 80.297  Millions
U s Stem Cell Inc   75.36 %$ 0.015  Millions$ 0.020  Millions
Castle Biosciences Inc   75.17 %$ 28.818  Millions$ 38.338  Millions
Exact Sciences Corporation  72.37 %$ 400.208  Millions$ 552.995  Millions
Inotiv Inc   71.14 %$ 87.324  Millions$ 122.754  Millions
Fresh2 Group Ltd  69.19 %$ 1.208  Millions$ 1.746  Millions
Burning Rock Biotech Limited  67.47 %$ 55.101  Millions$ 81.662  Millions
Nrc Health  63.33 %$ 24.156  Millions$ 38.144  Millions
Luna Innovations Inc  60.99 %$ 19.335  Millions$ 31.701  Millions
Hologic Inc  57.52 %$ 617.900  Millions$ 1,074.200  Millions
Ispecimen inc   52.40 %$ 1.552  Millions$ 2.962  Millions
Mdxhealth Sa  51.87 %$ 19.219  Millions$ 37.054  Millions
Exagen Inc   50.85 %$ 6.528  Millions$ 12.837  Millions
Butterfly Network Inc   47.93 %$ 9.556  Millions$ 19.936  Millions
Charles River Laboratories International inc   45.16 %$ 496.718  Millions$ 1,099.843  Millions
American Shared Hospital Services  45.07 %$ 2.270  Millions$ 5.037  Millions
Genetron Holdings Ltd  43.25 %$ 40.804  Millions$ 94.344  Millions
Natera Inc   41.65 %$ 90.482  Millions$ 217.252  Millions
Centogene N v   41.63 %$ 22.132  Millions$ 53.170  Millions
Koninklijke Philips Nv  40.35 %$ 8,057.280  Millions$ 19,966.240  Millions
Psychemedics Corporation  39.37 %$ 2.245  Millions$ 5.703  Millions
Iqvia Holdings Inc   35.62 %$ 1,332.000  Millions$ 3,739.000  Millions
Somalogic Inc   35.19 %$ 6.625  Millions$ 18.829  Millions
Quest Diagnostics Inc  32.49 %$ 758.000  Millions$ 2,333.000  Millions
Capforce Inc   31.40 %$ 0.227  Millions$ 0.722  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.